Browsing Tag
Immuron Limited
2 posts
Immuron (ASX: IMC) takes PROIBS to US as Nasdaq ADR jumps 62%
Immuron Limited has signed an exclusive U.S. distribution agreement with Sweden’s Calmino group AB for PROIBS, extending its digestive-health portfolio beyond Travelan after reporting record FY26 sales of A$7.7 million.
Immuron secures FDA greenlight to begin human studies of IMM-529 against C. difficile infection
Immuron gains FDA IND approval for IMM-529, advancing its oral antibody therapy into human trials for C. difficile infection.